Major Rating Factors:
Fair long-term capitalization index (4.8 on a scale of 0 to 10) based on fair current risk adjusted capital (moderate loss scenarios). Weak profitability index (2.6) with operating losses during 2022 and 2024. Average return on equity over the last five years has been poor at -0.4%. Weak overall results on stability tests (1.9) including weak risk adjusted capital in prior years, weak risk diversification and negative cash flow from operations for 2024.
Other Rating Factors:
Ample reserve history (10.0) that helps to protect the company against sharp claims increases. Superior liquidity (9.1) with ample operational cash flow and liquid investments.
Stability Factors:
C - Past results on our Risk-Adjusted Capital tests.
D - Limited diversification of general business, policy, and/or investment risk.
F - Negative cash flow.
R - Concerns about the financial strength of its reinsurers.
T - Significant trends in critical asset, liability, income or expense items.
Principal Lines of Business:
Med mal (99.4%), other (0.6%)
Licensed in:
DC
Principal Investments:
Investment grade bonds (83.6%), common stock (12.1%), cash (4.3%)
Ratios
Premium to Surplus
Reserve to Surplus
1-Year Reserve Development
2-Year Reserve Development
Expense Ratio
Combined Ratio
Cash From Underwriting
Net Premium Growth
Investments in Affiliates
--
Corporate Info
Group Affiliation
None
Investment Rating
--
Company Address
6 Wellness Way
Latham, NY 12110
Latham, NY 12110
Phone Number
(802) 264-9555
NAIC Number
15798
Website
--
Largest Affiliates
No affiliate information available.